Concepedia

Hematologic Toxicity Assessment

Hematologic Toxicity Assessment is a systematic method within the domain of toxicity risk evaluation that specifically measures and analyzes adverse effects of therapeutic agents or environmental exposures on hematopoietic and blood-related parameters, distinguishing it from other toxicity assessments by its focus on hematologic indices such as hemoglobin levels, white blood cell counts, platelet counts, and bone marrow function.

1K

Publications

56K

Citations

6.3K

Authors

1.5K

Institutions

Publications per year

2017–2026

129

Variants

Hematological Toxicity AssessmentHematotoxicity Assessment

Parents

Publications

1K

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text

, , +17

The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex

Douglas D. Richman, Margaret A. Fischl, Michael H. Grieco et al. · New England Journal of Medicine · 1987 · 1.2K citations

, , +15

<sup>225</sup>Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer

Clemens Kratochwil, Frank Bruchertseifer, Frederik L. Giesel et al. · Journal of Nuclear Medicine · 2016 · 1.1K citations · Full text

, , +17

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

Andrew Webb, David Cunningham, J.H. Scarffe et al. · Journal of Clinical Oncology · 1997 · 873 citations

, , +15

A Southwest Oncology Group study

Terry R. Jenkins, Catherine M. Tangen, John S. Macdonald et al. · 1993 · 775 citations

, , +12

1–5 of 1K

Authors

6.3K

  1. HM
    Hagop M. Kantarjian

    The University of Texas MD Anderson Cancer Center, United States

    11 publications · 350 citations

    11

    h-index

  2. JE
    Jörge E. Cortes

    The University of Texas MD Anderson Cancer Center, United States

    7 publications · 195 citations

    7

    h-index

  3. DM
    David M. Goldenberg

    Center for Molecular Medicine and Immunology, United States

    6 publications · 394 citations

    6

    h-index

  4. MB
    Massimo Breccia

    Sapienza University of Rome, Italy

    6 publications · 1.8K citations

    6

    h-index

  5. SO
    Susan O’Brien

    The University of Texas MD Anderson Cancer Center, United States

    6 publications · 208 citations

    6

    h-index

1–5 of 6.3K

Institutions

1.5K

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    24 h-index

    175 publications

    8.1K citations

  2. Memorial Sloan Kettering Cancer Center

    New York, United States

    19 h-index

    185 publications

    10.1K citations

  3. National Cancer Institute

    Bethesda, United States

    19 h-index

    107 publications

    8.8K citations

  4. Dana-Farber Cancer Institute

    Boston, United States

    17 h-index

    74 publications

    7.6K citations

  5. National Institutes of Health

    Bethesda, United States

    17 h-index

    86 publications

    5.5K citations

  6. Duke Medical Center

    Durham, United States

    15 h-index

    45 publications

    2.9K citations

  7. University of California, San Francisco

    San Francisco, United States

    15 h-index

    60 publications

    5.4K citations

  8. Johns Hopkins University

    Baltimore, United States

    14 h-index

    93 publications

    8.6K citations

1–8 of 1.5K

Venues

  1. Journal of Clinical Oncology

    129 publications · 15.1K citations

    70

    h-index

  2. Cancer

    104 publications · 5.7K citations

    46

    h-index

  3. PubMed

    Repository · 120 publications · 4K citations

    33

    h-index

  4. American Journal of Clinical Oncology

    AJCO · 36 publications · 903 citations

    18

    h-index

  5. Clinical Cancer Research

    16 publications · 1.5K citations

    16

    h-index

1–5